BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND Ki-67 AND Clinical Outcome
18 results:

  • 1. It is more than uterine fibroids: Incidental discovery of adenoma malignum of the cervix.
    Abada E
    Malays J Pathol; 2022 Dec; 44(3):533-538. PubMed ID: 36591722
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [A tumor of the uterus with a falsely benign aspect].
    Tauziède-Espariat A; Georges O
    Ann Pathol; 2022 Nov; 42(6):462-466. PubMed ID: 35034828
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Up-regulation of inflammation-related LncRNA-IL7R predicts poor clinical outcome in patients with cervical cancer.
    Fan Y; Nan Y; Huang J; Zhong H; Zhou W
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29720427
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [The clinical characteristics of pulmonary benign metastasizing leiomyoma].
    Wang HP; Shi JH; Zhang L
    Zhonghua Nei Ke Za Zhi; 2017 Jul; 56(7):490-494. PubMed ID: 28693056
    [No Abstract]    [Full Text] [Related]  

  • 5. clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma.
    Li M; Zhao L; Shen D; Li X; Wang J; Wei L
    Chin Med J (Engl); 2014; 127(8):1459-63. PubMed ID: 24762589
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
    Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
    Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Tubal metaplasia of the endometrium with cytologic atypia: analysis of p53, ki-67, TERT, and long-term follow-up.
    Simon RA; Peng SL; Liu F; Quddus MR; Zhang C; Steinhoff MM; Lawrence WD; Sung CJ
    Mod Pathol; 2011 Sep; 24(9):1254-61. PubMed ID: 21572399
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immunohistochemical evaluation and lymph node metastasis in surgically staged endometrial carcinoma.
    Pilka R; Marková I; Dusková M; Procházka M; Tozzi M; Kudela M
    Eur J Gynaecol Oncol; 2010; 31(5):530-5. PubMed ID: 21061794
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
    Kamat AA; Coffey D; Merritt WM; Nugent E; Urbauer D; Lin YG; Edwards C; Broaddus R; Coleman RL; Sood AK
    Cancer; 2009 Jun; 115(12):2684-92. PubMed ID: 19396818
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Squamous morules are functionally inert elements of premalignant endometrial neoplasia.
    Lin MC; Lomo L; Baak JP; Eng C; Ince TA; Crum CP; Mutter GL
    Mod Pathol; 2009 Feb; 22(2):167-74. PubMed ID: 19180120
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Expression of p53, ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer].
    Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M
    Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. GPR30: a novel indicator of poor survival for endometrial carcinoma.
    Smith HO; Leslie KK; Singh M; Qualls CR; Revankar CM; Joste NE; Prossnitz ER
    Am J Obstet Gynecol; 2007 Apr; 196(4):386.e1-9; discussion 386.e9-11. PubMed ID: 17403429
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
    Abd-Elaziz M; Akahira J; Moriya T; Suzuki T; Yaegashi N; Sasano H
    Cancer Sci; 2003 Nov; 94(11):980-5. PubMed ID: 14611675
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study.
    van Muyden RC; ter Harmsel BW; Smedts FM; Hermans J; Kuijpers JC; Raikhlin NT; Petrov S; Lebedev A; Ramaekers FC; Trimbos JB; Kleter B; Quint WG
    Cancer; 1999 May; 85(9):2011-6. PubMed ID: 10223243
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression of p150 in cervical neoplasia and its potential value in predicting survival.
    Dellas A; Torhorst J; Bachmann F; Bänziger R; Schultheiss E; Burger MM
    Cancer; 1998 Oct; 83(7):1376-83. PubMed ID: 9762939
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations.
    Dellas A; Moch H; Schultheiss E; Feichter G; Almendral AC; Gudat F; Torhorst J
    Gynecol Oncol; 1997 Oct; 67(1):27-33. PubMed ID: 9345352
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.
    Levine EL; Renehan A; Gossiel R; Davidson SE; Roberts SA; Chadwick C; Wilks DP; Potten CS; Hendry JH; Hunter RD
    Radiother Oncol; 1995 Oct; 37(1):1-9. PubMed ID: 8539450
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.